MEG3 and cancer: Given its predominant role in the MLMI network, we investigated how the overexpression of MEG3 altered the expression profiles in a normal hepatic cell line (LO2) and one of the hepatocellular cell lines (HepG2), since the expression of MEG3 was increased in the cancer tissues (\documentclass[12pt]{minimal}\usepackage{amsmath}\usepackage{wasysym}\usepackage{amsfonts}\usepackage{amssymb}\usepackage{amsbsy}\usepackage{mathrsfs}\usepackage{upgreek}\setlength{\oddsidemargin}{-69pt}\begin{document}$${\log }2({FC})$$\end{document}log2(FC) = 2.66; p = 0.003) in our sequenced cohort.